The fifth quarter of 2020: The economy may not truly turn the page until spring

Overview
1.
2.
3.
It might be 2021, but it doesn’t feel like a new year in many parts of the world. We haven’t yet turned the page on all the difficulties of the past year, so it seems like we are stuck in 2020. Or as my colleague aptly put it, this is just December 49th, 2020.
Vaccinations moving slowly in many parts of the world
Let’s start with COVID-19. Things aren’t getting better globally in terms of controlling the virus. The US and the UK look particularly challenged. And the holiday season could have been one giant superspreader event for those who did not stay isolated. Germany has had record daily COVID-19 infections — and deaths — for the last several weeks. Even Pope Francis’ personal physician died last week of the virus.
There is also less progress than expected on the distribution of vaccines in numerous countries. France has vaccinated only 0.29 per 100 people while Germany has vaccinated only 0.82 per 100 people and Canada has vaccinated 1.03 per 100 people.1 Spain has vaccinated only 1.04 per 100 people, the US has vaccinated only 2.82 per 100 people while the UK has vaccinated 4.19 per 100 people.1 We can all learn from Israel, which has vaccinated 22.34 per 100 people, helped by a digitized universal health care system, a widespread ad campaign and good planning, purchasing doses early on in order to cover the entire population.1 That so many countries have made so little progress is concerning because medical experts estimate that 55.6% to 81.5% of the total population should be vaccinated in order to bring an end to COVID-19.2
Economic data shows continued pressure
Recent economic data has shown signs of the damage being wrought by the rise in COVID-19 infections. The December jobs reports for both the US and Canada were disappointing, as was last week’s US initial jobless claims. We also saw weakness in US retail sales for December.
As for the eurozone economy, it also came under pressure in December. As Chris Williamson of IHS Markit explained, “The eurozone economy contracted for a second successive month in December, deteriorating at a slightly faster rate than previously thought at the end of the year due to intensifying COVID-19 infections.”3
I would expect economic data to continue to show weakness in the next several months as the virus continues to spread.
Stimulus talk didn’t help US stocks last week
Also last week, US President-elect Joe Biden released details of his $1.9 trillion stimulus package proposal, titled “The American Rescue and Recovery Plan.” But the market reaction was different than what we saw with past tranches of stimulus, with stocks selling off. Some suggested it could be that expectations of stimulus were already baked into stocks while others placed the blame on his talk of taxes. I think his discussion of raising taxes is responsible, sending US stocks lower on Friday. It also served as a reminder of all the additional spending many countries have done and the accompanying debt they have taken on to combat COVID-19, and the significant consequences.
More of the same for 1Q?
And so I think we should expect more of the same for the next several months. I suspect the first quarter of 2021 will really just be the fifth quarter of 2020, with continued headwinds for many economies. I worry about some risks:
· COVID-19. I talked about slow progress with vaccinations. What’s worse is the variants of the virus that have emerged. Medical experts are not sure whether current vaccines will protect against these recent variants. Doctors believe that the vaccines are effective against the far more contagious UK variant (which is projected to become the dominant strain of the virus in the US by March) — but there are no widespread studies to support that belief yet. And there is more concern that the South African variant may not be protected against by current vaccines. Even if the vaccines do protect against all these variants, I worry that these more contagious strains will cause an even bigger increase in infections, hospitalizations and deaths – and an even bigger decrease in economic activity — in the next several months before vaccines are broadly distributed. German Chancellor Angela Merkel is so worried about these COVID mutations that she has alerted lawmakers that the country should remain in lockdown until early April, explaining “If we don’t manage to stop this British virus, then we will have 10 times the number of cases by Easter. We need eight to 10 more weeks of tough measures.”4
· Distribution headwinds. Various countries are running into distribution glitches related to supply and infrastructure. Many emerging markets countries don’t have enough supply of the vaccine, as wealthier countries have bought up the vaccines. Some developed countries may not have enough supply either. In the US, President-elect Joe Biden last week announced an ambitious plan to vaccinate 100 million Americans in his first 100 days in office by building out a strong federal infrastructure, utilizing the Federal Emergency Management Agency (FEMA) and the National Guard. However, US Health and Human Services Secretary Alex Azar announced last week that there is no vaccine stockpile left in the US, which could slow down those vaccine plans. I wouldn’t be surprised to see more distribution hiccups in many countries in the next several months.
There is also one risk specific to markets: the potential for monetary policy to tighten more quickly than expected — or, to be more accurate, investors worrying that monetary policy will tighten more quickly than expected. This concern is centered on the Federal Reserve, given trepidation that stimulus might actually push inflation higher and force the Fed’s hand.
Admittedly, there have been a few Fed officials who have made comments recently that could cause indigestion for investors on a sugar high from ultra-low rates. However, last week Fed Chair Jay Powell tried to assuage fears about tightening, saying that the Fed would be very careful in communicating about any changes in policy and that the Fed would avoid premature tightening. He explained that “(One) lesson of the global financial crisis is: be careful not to exit too early” and that central bankers shouldn’t even try to discuss exiting “because the markets are already listening.”5
Yes, markets are listening because there is so much worry about this topic. For the record, I continue to believe it is unlikely we see inflation spike substantially — but it remains an investor concern. I think markets could swoon on just words alone — or, to put it more accurately, just misinterpreting words.
A light at the end of the tunnel?
I must stress that I believe there is a very bright light at the end of the tunnel. We just need to make it through the next few months. In other words, I believe we WILL be able to turn the page.
By this spring, I believe “Groundhog Year” will be over and headwinds will abate. I expect markets to continue to move in expectations of a robust recovery later in 2021 when vaccines are broadly distributed. That should benefit cyclical stocks, emerging market stocks (especially in Asia), and commodities that are sensitive to the economic cycle, especially energy and industrial metals. I do expect tech to continue perform well, given that many of the trends that accelerated during the pandemic may not reverse. As always, I believe investors should be prudent, which means maintaining a well-diversified portfolio to help lower overall volatility, which is a likely risk in this environment.
Related articles
Keep up-to-date
Sign up to receive the latest insights from Invesco’s global team of experts and details about on demand and upcoming online events.
Investment risks
-
The value of investments and any income will fluctuate (this may partly be the result of exchange rate fluctuations) and investors may not get back the full amount invested.
Important information
-
All data is as at 31 December 2020 unless otherwise stated.
This document is marketing material and is not intended as a recommendation to invest in any particular asset class, security or strategy. Regulatory requirements that require impartiality of investment/investment strategy recommendations are therefore not applicable nor are any prohibitions to trade before publication. The information provided is for illustrative purposes only, it should not be relied upon as recommendations to buy or sell securities.
Where individuals or the business have expressed opinions, they are based on current market conditions, they may differ from those of other investment professionals, they are subject to change without notice and are not to be construed as investment advice.